Status:
COMPLETED
Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
Lead Sponsor:
Stanford University
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Diabetes, Gestational
Eligibility:
FEMALE
18-50 years
Phase:
PHASE1
PHASE2
Brief Summary
Diabetic pregnant patients are at risk for adverse pregnancy outcomes, including larger than expected fetuses and unplanned operative deliveries, due to elevated blood glucose levels. the one-hour glu...
Detailed Description
All pregnant patients without pre-existing diabetes will be eligible for the study. Interest in participation will be determined at their initial prenatal visit. Those that are interested will be cons...
Eligibility Criteria
Inclusion
- Pregnant patients
- Age 18-50
- Gestational age less than 28 weeks
Exclusion
- Minors less than 18 years of age
- Multiple gestation
- Known fetal anomalies
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT00850135
Start Date
February 1 2009
End Date
September 1 2015
Last Update
May 19 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Santa Clara Valley Medical Center
San Jose, California, United States, 95128
2
Stanford University School of Medicine
Stanford, California, United States, 94305